跳至主要内容
临床试验/CTRI/2022/12/048553
CTRI/2022/12/048553尚未招募未知

Median effective volume of 0.25% ropivacaine for Suprainguinal Fascia Iliaca Compartment Block [FICB] for positioning of hip fracture patients prior to neuraxial blockade: A prospective dose estimation study.

Dr Pradipta Kumar Behera0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients with age above 18 years undergoing surgery for hip fracture under sub-arachnoid blockade
  • 2) BMI:18-30 kg/m2
  • 3) ASA physical status: I-III

排除标准

  • 1) Allergy to local anaesthestics drugs.
  • 2) Any contraindication to neuraxial blockade like local infection at site of injection, raised intacranial pressure, spine trauma.
  • 3) Prothrombin Time INR greater than 1.5,Platelet count less than 75,000/cmm
  • 4) Patient refusal to FICB/ neuraxial blockade.
  • 5) Previous surgery in suprainguinal region.
  • 6) Patient unable to understand the procedure.

研究者

发起方
Dr Pradipta Kumar Behera

相似试验